Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer

The aim of the study was to systematically explore the relationships between various adipokines and risks of endometrial atypical hyperplasia (EAH), type I endometrial cancer (EC), and type II EC. We enrolled 219 patients in this study, including 39 EAH, 87 type I EC, 38 type II EC and 55 control in...

Full description

Bibliographic Details
Main Authors: Xinxin Zhu, Linzhi Liu, Zonghao Feng, Yan Zhang
Format: Article
Language:English
Published: Taylor & Francis Group 2023-12-01
Series:Journal of Obstetrics and Gynaecology
Subjects:
Online Access:http://dx.doi.org/10.1080/01443615.2023.2179914
_version_ 1797685652834222080
author Xinxin Zhu
Linzhi Liu
Zonghao Feng
Yan Zhang
author_facet Xinxin Zhu
Linzhi Liu
Zonghao Feng
Yan Zhang
author_sort Xinxin Zhu
collection DOAJ
description The aim of the study was to systematically explore the relationships between various adipokines and risks of endometrial atypical hyperplasia (EAH), type I endometrial cancer (EC), and type II EC. We enrolled 219 patients in this study, including 39 EAH, 87 type I EC, 38 type II EC and 55 control individuals. We subsequently explored the association of adipokine levels and the leptin-to-adiponectin (L/A) ratio with EAH, type I EC, and type II EC. The plasma leptin level and L/A ratio were significantly higher in the EAH group than in the control group (p = 0.012). Leptin, resistin, vaspin, and visfatin levels were significantly higher in the type I EC group; however, the adiponectin level was lower in the type I EC, which resulted in a higher L/A ratio. Notably, the L/A ratio and visfatin level in the type II EC group were significantly higher. Multiple logistic regression analysis revealed that a higher leptin level was significantly associated with a higher EAH risk (p = 0.012). Higher leptin level (p = 0.042) and L/A ratio (p = 0.027) were significantly associated with an increased type I EC risk. By contrast, higher leptin (p = 0.059) and visfatin (p = 0.003) levels, higher L/A ratio (p = 0.033), and lower adiponectin level (p = 0.042) were associated with an increased type II EC risk. We suggested that adipokines are potentially correlated with EAH and EC risks.
first_indexed 2024-03-12T00:47:47Z
format Article
id doaj.art-1c9c546626dc400ab735331aa2547704
institution Directory Open Access Journal
issn 0144-3615
1364-6893
language English
last_indexed 2024-03-12T00:47:47Z
publishDate 2023-12-01
publisher Taylor & Francis Group
record_format Article
series Journal of Obstetrics and Gynaecology
spelling doaj.art-1c9c546626dc400ab735331aa25477042023-09-14T15:29:13ZengTaylor & Francis GroupJournal of Obstetrics and Gynaecology0144-36151364-68932023-12-0143110.1080/01443615.2023.21799142179914Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancerXinxin Zhu0Linzhi Liu1Zonghao Feng2Yan Zhang3Department of Obstetrics and Gynecology, Peking University First HospitalDepartment of Obstetrics and Gynecology, Peking University First HospitalDepartment of Obstetrics and Gynecology, Peking University First HospitalDepartment of Obstetrics and Gynecology, Peking University First HospitalThe aim of the study was to systematically explore the relationships between various adipokines and risks of endometrial atypical hyperplasia (EAH), type I endometrial cancer (EC), and type II EC. We enrolled 219 patients in this study, including 39 EAH, 87 type I EC, 38 type II EC and 55 control individuals. We subsequently explored the association of adipokine levels and the leptin-to-adiponectin (L/A) ratio with EAH, type I EC, and type II EC. The plasma leptin level and L/A ratio were significantly higher in the EAH group than in the control group (p = 0.012). Leptin, resistin, vaspin, and visfatin levels were significantly higher in the type I EC group; however, the adiponectin level was lower in the type I EC, which resulted in a higher L/A ratio. Notably, the L/A ratio and visfatin level in the type II EC group were significantly higher. Multiple logistic regression analysis revealed that a higher leptin level was significantly associated with a higher EAH risk (p = 0.012). Higher leptin level (p = 0.042) and L/A ratio (p = 0.027) were significantly associated with an increased type I EC risk. By contrast, higher leptin (p = 0.059) and visfatin (p = 0.003) levels, higher L/A ratio (p = 0.033), and lower adiponectin level (p = 0.042) were associated with an increased type II EC risk. We suggested that adipokines are potentially correlated with EAH and EC risks.http://dx.doi.org/10.1080/01443615.2023.2179914adipokineendometrial atypical hyperplasiatype i endometrial cancertype ii endometrial cancerinsulin resistancerisk factor
spellingShingle Xinxin Zhu
Linzhi Liu
Zonghao Feng
Yan Zhang
Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
Journal of Obstetrics and Gynaecology
adipokine
endometrial atypical hyperplasia
type i endometrial cancer
type ii endometrial cancer
insulin resistance
risk factor
title Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
title_full Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
title_fullStr Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
title_full_unstemmed Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
title_short Correlation of plasma adipokines with endometrial atypical hyperplasia and type I/II endometrial cancer
title_sort correlation of plasma adipokines with endometrial atypical hyperplasia and type i ii endometrial cancer
topic adipokine
endometrial atypical hyperplasia
type i endometrial cancer
type ii endometrial cancer
insulin resistance
risk factor
url http://dx.doi.org/10.1080/01443615.2023.2179914
work_keys_str_mv AT xinxinzhu correlationofplasmaadipokineswithendometrialatypicalhyperplasiaandtypeiiiendometrialcancer
AT linzhiliu correlationofplasmaadipokineswithendometrialatypicalhyperplasiaandtypeiiiendometrialcancer
AT zonghaofeng correlationofplasmaadipokineswithendometrialatypicalhyperplasiaandtypeiiiendometrialcancer
AT yanzhang correlationofplasmaadipokineswithendometrialatypicalhyperplasiaandtypeiiiendometrialcancer